tiletamine hydrochloride has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anıl, B; Biçer, A; Gülcin, İ; Gültekin, MS; Kaya, R; Turgut Cin, G | 1 |
| Amjad, MW; Bukhari, SN; Hussain, MA; Hussain, Z; Jantan, I; Qin, HL; Sher, M; Zha, GF; Zhang, CP | 1 |
2 other study(ies) available for tiletamine hydrochloride and Alzheimer Disease
| Article | Year |
|---|---|
Synthesis of novel bis-sulfone derivatives and their inhibition properties on some metabolic enzymes including carbonic anhydrase, acetylcholinesterase, and butyrylcholinesterase.
Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Cholinesterase Inhibitors; Cyclohexanones; Humans; Magnetic Resonance Imaging; Protein Conformation; Spectroscopy, Fourier Transform Infrared; Structure-Activity Relationship; Sulfones | 2019 |
Biological evaluation of synthetic α,β-unsaturated carbonyl based cyclohexanone derivatives as neuroprotective novel inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-β aggregation.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Butyrylcholinesterase; Cell Survival; Cholinesterase Inhibitors; Cyclohexanones; Drug Design; Humans; Neuroprotective Agents; PC12 Cells; Peptide Fragments; Protein Aggregates; Rats | 2016 |